Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Filings indexed 1,124 across all filing types
Latest filing 2009-04-17 Regulatory Filings
Country SE Sweden
Listing ST EKTA

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2009
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'Press Release' and details a business transaction (Elekta delivering technology to The Mind Research Network). It announces a specific event/agreement rather than reporting periodic financial results (ER, IR, 10-K), management changes (MANG), or shareholder votes (DVA). Since it is a general announcement about a business development, and there is no specific category for 'Business Development' or 'Contract Award', the most appropriate fallback category is 'Regulatory Filings' (RNS), as press releases often fall under general regulatory disclosure requirements, although it is not a formal SEC filing type listed. Given the options, RNS serves as the best general disclosure category for non-standard announcements.
2009-04-17 English
Share Issue/Capital Change 2009
Share Issue/Capital Change Classification · 1% confidence The document is titled 'NUMBER OF SHARES IN ELEKTA AS OF MARCH 31, 2009' and is explicitly labeled as a 'Press Release'. It reports a change in the total number of shares due to the cancellation of treasury shares, which is a change in the company's capital structure. This directly aligns with the definition of 'Share Issue/Capital Change' (SHA), which covers changes in capital structure, including share cancellations. Although it is a press release, the core content is a mandatory disclosure about the share count, making SHA a more specific fit than the general 'RNS' or 'RPA'. The document length is short, but the content is the actual capital change data, not just an announcement that data is available elsewhere.
2009-03-31 English
Share Issue/Capital Change 2009
Share Issue/Capital Change Classification · 1% confidence The document is a short press release (1934 characters) issued on March 31, 2009, titled 'ANTAL UTESTÅENDE AKTIER I ELEKTA PER DEN 31 MARS 2009' (Number of outstanding shares in Elekta as of March 31, 2009). It explicitly states that according to regulations, the company must disclose the total number of shares monthly if a change occurred. The text details that 951,300 B-shares were cancelled (makulerades) from treasury stock, resulting in a new total outstanding share count. This action—the cancellation of treasury shares—falls under capital structure changes or share transactions. Given the options, 'Transaction in Own Shares' (POS) is the most precise fit as it reports on the company's own shares being cancelled/repurchased. It is not a general financing update (CAP) or a major shareholding notification (MRQ) which usually relates to external investors crossing thresholds. It is a direct report of a share transaction/change.
2009-03-31 Swedish
Regulatory Filings 2009
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'Press Release' and details a specific clinical event (a patient receiving treatment with a new radiotherapy system) and includes contact information for Investor Relations. This format is characteristic of an announcement intended for the public and media, often released concurrently with or preceding formal regulatory filings. Since it is not a comprehensive financial report (10-K, IR), an earnings summary (ER), or a formal shareholder communication (DEF 14A, PSI), the most appropriate classification for a general, non-financial, news-style announcement from a company is 'Regulatory Filings' (RNS), which serves as a broad category for general corporate announcements that don't fit elsewhere, or potentially 'LTR' if it were about a legal matter, but here it is a product/clinical milestone announcement. Given the options, RNS is the best fit for a general press release that isn't an earnings release or a specific regulatory disclosure like insider trading or capital change.
2009-03-12 English
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 1% confidence The document is a 'Niomånadersrapport' (Nine-month report) for Elekta, covering the period from May to January 2008/09. It contains detailed financial statements, including income statements, cash flow data, regional market analysis, and management commentary on financial performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2009
2009-03-05 Swedish
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim report' for the period May–January 2008/09. It contains detailed financial statements, including order bookings, net sales, operating profit, and cash flow, along with management commentary and market analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H2 2009
2009-03-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.